<?xml version="1.0" encoding="UTF-8"?>
<p id="Par54">AD is a syndrome characterized by immune dysregulation, but there is no evidence at present, nor any clinical reporting, which suggests that affected people are more likely to develop COVID-19 and/or to experience a more severe form [
 <xref ref-type="bibr" rid="CR24">24</xref>, 
 <xref ref-type="bibr" rid="CR25">25</xref>]. It is not currently known whether the transmission of the SARS-CoV-2 infection is more likely to occur in subjects with active or exuding skin lesions. However, as coronavirus appears to spread through respiratory droplets, it appears highly unlikely that a damaged skin barrier increases the risk of developing COVID-19.
</p>
